Market Scenario
The
global apheresis market size is
projected to grow at a 8.90 % CAGR during the forecast period (2023-2030). The
apheresis market is witnessing significant growth globally, driven by
advancements in technology, increasing prevalence of chronic diseases, and
rising demand for blood components and plasma-derived therapies. Apheresis, a
medical procedure involving the separation and extraction of blood components
such as plasma, platelets, or white blood cells, plays a crucial role in
treating various conditions including autoimmune disorders, neurological
diseases, and hematologic malignancies. The market is characterized by a
growing number of applications, including therapeutic apheresis for treating
diseases like leukemia and myasthenia gravis, as well as the collection of
blood components for transfusion and research purposes.
Technological
innovations and the introduction of automated apheresis systems are driving
market expansion, offering improved efficiency, reduced procedure times, and
enhanced safety for patients. Moreover, the increasing demand for personalized
medicine and targeted therapies is expected to fuel further market growth as
apheresis procedures enable the precise extraction and manipulation of specific
blood components tailored to individual patient needs. With a rising emphasis
on blood safety and the growing adoption of apheresis procedures in both
developed and developing regions, the global apheresis market is projected to
continue its upward trajectory in the coming years, presenting lucrative
opportunities for market players and healthcare providers alike.
The
Apheresis market is witnessing significant growth, driven by the increasing
adoption of advanced therapeutic procedures such as selective plasma filtration
and plasma pheresis. Selective
plasma filtration is a cutting-edge technique
that allows for the precise removal of targeted substances from the blood,
offering a tailored approach to treating various medical conditions. This
process involves separating plasma from blood cells, passing it through a
specialized filter to remove specific components, and then returning the
purified plasma back to the patient's circulation. By selectively removing
harmful substances while preserving essential blood components, selective
plasma filtration has emerged as a promising tool in the treatment of
autoimmune disorders, neurological diseases, and certain cancers.
Competitive Dashboard
The
Major Apheresis Players operating
the global market are Kaneka Corporation (Japan), Terumo BCT Inc. (US),
Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical
Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan),
HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation
(US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others.
Drivers and Constraints Impacting the Market
With
the growing prevalence of chronic renal diseases and blood-related diseases,
the global apheresis market is considered to stimulate during the
estimated period. Increasing complex surgical procedures, rising demand for
different component of blood, and growing number of accidents across the globe
are considered to augment the market growth in the coming years. Demand for
platelets and plasma has also increased which is further impacting the global
market positively. Moreover, with continuous advancement in technology and
growing need for advanced and automated devices, the market is likely to
foster.
On
the flip side, high cost of procedures and lack of skilled professionals are
some of the major factors considered to impede the market growth in the coming
years.
Global Apheresis Market: Segmental Analysis
The
global apheresis market has been segmented on the basis of product, procedure,
methods, application, end-users, and region.
By
mode of product, global apheresis market has been segmented into devices and
disposables. The devices segment has been further sub-segmented into platelets
separators, plasma separators, and others.
By
mode of procedure, the global apheresis market has been segmented into
leukapheresis, plateletpheresis, plasmapheresis, erythrocytapheresis, and
others.
By
mode of methods, the global apheresis market has been segmented into filtration
and centrifugation. Among these, centrifugation is further sub-segmented into
intermittent flow centrifugation, continuous flow centrifugation, and others.
By
mode of application, the global apheresis market has been segmented into
oncological diseases, immunological diseases, hematological diseases,
cardiovascular diseases, renal diseases, neurological diseases, and others.
By
mode of end-users, the global apheresis market has been segmented into
hospitals, blood banks, and others.
Regional Insights
Geographically,
apheresis market span across regions namely, America, Europe, Asia Pacific, and
Rest-of-the-World (RoW).
Among
all the regions, America is considered to hold the largest position in the
global market and is expected to maintain its dominance during the assessment
period. The growth is attributed to the advancement in technology and growing
opportunity for apheresis products coupled with the presence of a huge patient
population suffering from chronic diseases.
Asia
Pacific is considered to be the fastest growing region in the global market
owing to the growing demand for blood components for patients. Moreover, rapid
development in the healthcare industry along with growing expenditure on health
care is considered to contribute to the growth of the global market.
Related Reports-
